Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up

Mariachiara Sensi, Giovanni Cossu, Francesca Mancini, Manuela Pilleri, Maurizio Zibetti, Nicola Modugno, Rocco Quatrale, Filippo Tamma, Angelo Antonini, Marco Aguggia, Marianna Amboni, Roberta Arca, Luigi Bartolomei, Nicola Bonetto, Giovanna Calandra-Buonaura, Francesco Bove, Daniela Calandrella, Margherita Canesi, Antonino Cannas, Marianna CapecciElena Caputo, Maria Gabriella Ceravolo, Roberto Ceravolo, Gloria Cerrone, Mario Coletti Moja, Cristoforo Comi, Pietro Cortelli, Paola D'Antonio, Francesca Dematteis, Vincenzo Di Lazzaro, Roberto Eleopra, Giovanni Fabbrini, Mario Fichera, Enrico Grassi, Marco Guido, Graziano Gusmaroli, Anna Latorre, Maria Chiara Malaguti, Massimo Marano, Pietro Marano, Roberto Marconi, Sonia Mazzucchi, Giuseppe Meco, Brigida Minafra, Francesca Morgante, Claudio Pacchetti, Mariangela Pierantozzi, Francesco E. Pontieri, Giulio Riboldazzi, Valeria Ricchi, on behalf of the, ITALIAN LEVODOPA CARBIDOPA INTESTINAL GEL WORKING GROUP

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up'. Together they form a unique fingerprint.

Medicine & Life Sciences